Inaugural LGDA Science Award

For extraordinary accomplishments in discovery and advancement in the field of lymphatic science for the benefit of our worldwide patient community  presented to

Michael T. Dellinger, PhD

Assistant Professor

Division of Surgical Oncology

Department of Surgery

Hamon Center for Therapeutic Oncology Research

UT Southwestern Medical Center

Dallas, Texas

 

The LGDA’s award for a scientist was made at the 2nd International Patient & Family Conference in Dallas, in July, 2018.  The first recipient of the award for extraordinary accomplishments in discovery and advancement in the field of lymphatic science for his work and accomplishments in understanding Gorham-Stout disease and generalized lymphatic anomaly/GLA (formerly lymphangiomatosis) is Michael T. Dellinger, PhD, Assistant Professor, UT Southwestern Medical Center, Dallas.

Dr. Dellinger, a lymphatic molecular biologist, is the lead scientist for these orphan diseases. His lab has developed the first pre-clinical model for Gorham-Stout disease, an important research tool for the investigation of the cause and behavior of osteoclasts in the mysterious destruction of bone, and the role of lymphatic endothelial cells in osteolysis.  As Director of Research for the Lymphatic Malformation Institute, Dr. Dellinger has recruited other leading scientists in lymphatic research that have located the first genes known to have a role in our complicated lymphatic anomalies.  He has presented his work in numerous science and clinical research settings,  published his findings, and has recruited several young investigators to the field of lymphatic biology.  He is currently investigating how certain therapies act in the pathway where known lymphatic malformations can be intercepted.

Dr. Dellinger is a graduate of the University of Arizona, where he studied under Marlys Witte, MD, a noted pioneer in lymphatics. Dr. Dellinger lives in the Dallas area with his wife, Laura, a scientist, and their little boy, Henry.

This award is in recognition for Dr. Dellinger’s breakthrough accomplishments and the total of his work which has launched the search in earnest to stop the catastrophic threat of Gorham-Stout disease and generalized lymphatic anomaly that has taken the lives of so many of our community.

For the LGDA Board of Directors,  this award is presented – with so much gratitude that words can’t accommodate.

Scot Wiesner, Chairman, Jack Kelly, President.